NFRFX
Price
$17.80
Change
+$0.01 (+0.06%)
Updated
Jun 12 closing price
Net Assets
2.05B
PFFRX
Price
$9.25
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Net Assets
4.74B
Interact to see
Advertisement

NFRFX vs PFFRX

Header iconNFRFX vs PFFRX Comparison
Open Charts NFRFX vs PFFRXBanner chart's image
NFRFX vs PFFRX Comparison Chart in %
View a ticker or compare two or three
VS
NFRFX vs. PFFRX commentary
Jun 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NFRFX is a Hold and PFFRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PFFRX has more cash in the bank: 4.74B vs. NFRFX (2.05B). NFRFX pays higher dividends than PFFRX: NFRFX (7.34) vs PFFRX (6.86). NFRFX was incepted earlier than PFFRX: NFRFX (11 years) vs PFFRX (16 years). PFFRX (0.69) and NFRFX (0.68) have similar cost to investors . PFFRX is a more actively managed with annual turnover of: 107.30 vs. NFRFX (49.00). PFFRX has a lower initial minimum investment than NFRFX: PFFRX (2500) vs NFRFX (1000000). NFRFX annual gain was more profitable for investors over the last year : 5.80 vs. PFFRX (5.24). NFRFX (33.63) and PFFRX (33.45) have equivalent 5 years return.
NFRFXPFFRXNFRFX / PFFRX
Total Expense Ratio0.680.6999%
Annual Report Gross Expense Ratio0.680.6999%
Fund Existence11 years16 years-
Gain YTD1.6140.990163%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.05B4.74B43%
Annual Yield % from dividends7.346.86107%
Returns for 1 year5.805.24111%
Returns for 3 years27.2726.21104%
Returns for 5 years33.6333.45101%
Returns for 10 years69.0764.56107%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STUB11.460.84
+7.91%
Stubhub Holdings Inc
CETY1.010.07
+7.16%
Clean Energy Technologies Inc.
RVMD153.874.64
+3.11%
Revolution Medicines
IPHA1.780.04
+2.30%
Innate Pharma SA
LXRX1.920.03
+1.59%
Lexicon Pharmaceuticals